Rodrigues C, Gaifem J, Pereira M, Alves M, Silva M, Padrao N
Gut Microbes. 2025; 17(1):2461210.
PMID: 39918275
PMC: 11810091.
DOI: 10.1080/19490976.2025.2461210.
Nat Immunol. 2024; 25(9):1526-1527.
PMID: 39122923
DOI: 10.1038/s41590-024-01919-5.
Gaifem J, Rodrigues C, Petralia F, Alves I, Leite-Gomes E, Cavadas B
Nat Immunol. 2024; 25(9):1692-1703.
PMID: 39080486
PMC: 11362009.
DOI: 10.1038/s41590-024-01916-8.
Abdelbary M, Nolz J
Immunometabolism (Cobham). 2023; 5(4):e00035.
PMID: 38027254
PMC: 10662610.
DOI: 10.1097/IN9.0000000000000035.
Hale R, Morais D, Chou J, Stowell S
J Allergy Clin Immunol. 2023; 153(1):55-66.
PMID: 37717626
PMC: 10872775.
DOI: 10.1016/j.jaci.2023.09.003.
Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection.
Pinho S, Alves I, Gaifem J, Rabinovich G
Cell Mol Immunol. 2023; 20(10):1101-1113.
PMID: 37582971
PMC: 10541879.
DOI: 10.1038/s41423-023-01074-1.
Muscle glycome in idiopathic inflammatory myopathies: Impact in IL-6 production and disease prognosis.
Campar A, Alves I, Santos-Pereira B, Nogueira R, Mendonca Pinto M, Vasconcelos C
iScience. 2023; 26(7):107172.
PMID: 37404372
PMC: 10316658.
DOI: 10.1016/j.isci.2023.107172.
Mannosylated glycans impair normal T-cell development by reprogramming commitment and repertoire diversity.
Vicente M, Alves I, Fernandes A, M Dias A, Santos-Pereira B, Perez-Anton E
Cell Mol Immunol. 2023; 20(8):955-968.
PMID: 37344746
PMC: 10387478.
DOI: 10.1038/s41423-023-01052-7.
Development of an Antibody-Based Platform for the Analysis of Immune Cell-Specific N-linked Glycosylation.
Dressman J, McDowell C, Lu X, Angel P, Drake R, Mehta A
Anal Chem. 2023; 95(27):10289-10297.
PMID: 37293957
PMC: 10988393.
DOI: 10.1021/acs.analchem.3c00838.
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
de-Souza-Ferreira M, Ferreira E, de-Freitas-Junior J
Cell Oncol (Dordr). 2023; 46(3):481-501.
PMID: 36689079
DOI: 10.1007/s13402-023-00770-4.
CD4 T cell metabolism, gut microbiota, and autoimmune diseases: implication in precision medicine of autoimmune diseases.
Yang W, Yu T, Cong Y
Precis Clin Med. 2022; 5(3):pbac018.
PMID: 35990897
PMC: 9384833.
DOI: 10.1093/pcmedi/pbac018.
N-Glycosylation and Inflammation; the Not-So-Sweet Relation.
Radovani B, Gudelj I
Front Immunol. 2022; 13:893365.
PMID: 35833138
PMC: 9272703.
DOI: 10.3389/fimmu.2022.893365.
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Mortha A, Remark R, Del Valle D, Chuang L, Chai Z, Alves I
Gastroenterology. 2022; 163(3):659-670.
PMID: 35623454
PMC: 10127946.
DOI: 10.1053/j.gastro.2022.05.029.
Multiomics to elucidate inflammatory bowel disease risk factors and pathways.
Agrawal M, Allin K, Petralia F, Colombel J, Jess T
Nat Rev Gastroenterol Hepatol. 2022; 19(6):399-409.
PMID: 35301463
PMC: 9214275.
DOI: 10.1038/s41575-022-00593-y.
Emerging role of protein modification in inflammatory bowel disease.
Wang G, Yuan J, Luo J, Ocansey D, Zhang X, Qian H
J Zhejiang Univ Sci B. 2022; 23(3):173-188.
PMID: 35261214
PMC: 8913920.
DOI: 10.1631/jzus.B2100114.
Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation.
Brazil J, Parkos C
Mucosal Immunol. 2021; 15(2):211-222.
PMID: 34782709
PMC: 8591159.
DOI: 10.1038/s41385-021-00466-8.
The Role of Glycosylation in Inflammatory Diseases.
Alves I, Vicente M, M Dias A, Gaifem J, Rodrigues C, Campar A
Adv Exp Med Biol. 2021; 1325:265-283.
PMID: 34495540
DOI: 10.1007/978-3-030-70115-4_13.
Glycosylation in Autoimmune Diseases.
Zabczynska M, Link-Lenczowski P, Pochec E
Adv Exp Med Biol. 2021; 1325:205-218.
PMID: 34495537
DOI: 10.1007/978-3-030-70115-4_10.
Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study.
Leonard M, Valitutti F, Karathia H, Pujolassos M, Kenyon V, Fanelli B
Proc Natl Acad Sci U S A. 2021; 118(29.
PMID: 34253606
PMC: 8307711.
DOI: 10.1073/pnas.2020322118.
Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits.
Morosi L, Cutine A, Cagnoni A, Manselle-Cocco M, Croci D, Merlo J
Sci Adv. 2021; 7(25).
PMID: 34144987
PMC: 8213219.
DOI: 10.1126/sciadv.abf8630.